The Effect of Zoledronate on the Prevention of Pneumonia in Hip Fracture Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,692

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Hip FracturesPneumonia
Interventions
DRUG

Zoledronate

Aclasta Solution for Infusion 5mg/100ml (zoledronic acid)

Trial Locations (5)

Unknown

RECRUITING

Queen Mary Hospital, Hong Kong

RECRUITING

United Christian Hospital, Kwun Tong

RECRUITING

Caritas Medical Centre, Sham Shui Po

NOT_YET_RECRUITING

Prince of Wales Hospital, Shatin

RECRUITING

Tai Po Hospital, Tai Po

All Listed Sponsors
collaborator

Queen Mary Hospital, Hong Kong

OTHER

collaborator

Caritas Medical Centre, Hong Kong

OTHER

collaborator

Prince of Wales Hospital, Shatin, Hong Kong

OTHER

collaborator

United Christian Hospital

OTHER

lead

The University of Hong Kong

OTHER